Supply Chain Resilience Measures Included In Senate Coronavirus Bill

Whether major drug shortages result from the COVID-19 pandemic or not, manufacturers would face greater reporting requirements, especially for APIs.

Pill Production
coronavirus fears restore broken legislative supply chain

More from Legislation

More from Pink Sheet